Wikidata

(Q40753352)

English

A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease

scientific article published on January 2002

In more languages

Statements

title
A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017
author name string
Tom B Sculley
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017
Marion Buck
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017
Brian Gabrielli
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017
Kenia G Krauer
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017
publication date
1 January 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017
page(s)
271-279
1 reference
stated in
Europe PubMed Central
PubMed ID
11821743
retrieved
23 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40753352&oldid=1906695986"